These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11026170)

  • 1. Severe leukopenia with valproate.
    Storch DD
    J Am Acad Child Adolesc Psychiatry; 2000 Oct; 39(10):1208-9. PubMed ID: 11026170
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inadequate vasopressin secretion and valproate].
    Franco Hidalgo S; Prieto de Paula JM; Salado Valdivieso I
    Endocrinol Nutr; 2009 May; 56(5):277. PubMed ID: 19627751
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukopenia and neutropenia induced by quetiapine.
    Cowan C; Oakley C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):292-4. PubMed ID: 16930797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of valproate in an elderly population with affective symptoms.
    Kando JC; Tohen M; Castillo J; Zarate CA
    J Clin Psychiatry; 1996 Jun; 57(6):238-40. PubMed ID: 8666559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal effects of valproic acid?
    Garland EJ; Behr R
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1424-5. PubMed ID: 8936907
    [No Abstract]   [Full Text] [Related]  

  • 6. Pedal edema associated with addition of low-dose quetiapine to valproate treatment in bipolar disorder.
    Chen CY; Yeh YW; Kuo SC; Shiah IS; Liu PY; Chen CL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1551-2. PubMed ID: 19665043
    [No Abstract]   [Full Text] [Related]  

  • 7. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y; Annagur BB; Sayin AA; Akbaba N
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of polymorphonuclear leukocyte agglutination in vitro.
    Schinella M; Kojikara P; Curci V
    Haematologica; 1995; 80(2):196-7. PubMed ID: 7628757
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of divalproex in the treatment of addictive disorders.
    Myrick H; Brady KT
    Psychopharmacol Bull; 2003; 37 Suppl 2():89-97. PubMed ID: 15021864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stuttering as a side-effect of divalproex sodium.
    Aukst-Margetić B; Margetić B
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):748. PubMed ID: 19068016
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate and polycystic ovaries.
    Irwin M; Masand P
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):9-10. PubMed ID: 9444888
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of endogenous depressions with valpromide (open study).
    Svestka J; Rysánek R; Cesková E
    Homeost Health Dis; 1991; 33(5-6):291-2. PubMed ID: 18265503
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents.
    Rahman A; Mican LM; Fischer C; Campbell AH
    Ann Pharmacother; 2009 May; 43(5):822-30. PubMed ID: 19401471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature.
    Khoo CL; Naik S; Lua R; Chai SB; Liew A; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):561-2. PubMed ID: 20184937
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of valproate-induced hyperammonemia.
    Stewart JT
    J Am Geriatr Soc; 2005 Jun; 53(6):1080. PubMed ID: 15935047
    [No Abstract]   [Full Text] [Related]  

  • 16. Eosinophilic pleural effusion associated with the addition of sodium valproate.
    Fernández-Pérez R; Alvarez-Dobaño JM; Suárez-Antelo J; Codesido-Barcala R; Carballal-Calvo F; Arrojo-Romero M; de Leon J
    J Clin Psychopharmacol; 2009 Jun; 29(3):310-1. PubMed ID: 19440094
    [No Abstract]   [Full Text] [Related]  

  • 17. Quetiapine-induced leucopenia and thrombocytopenia.
    Shankar BR
    Psychosomatics; 2007; 48(6):530-1. PubMed ID: 18071101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia.
    Suzuki T; Uchida H; Takeuchi H; Nakajima S; Nomura K; Tanabe A; Yagi G; Watanabe K; Kashima H
    Hum Psychopharmacol; 2009 Dec; 24(8):628-38. PubMed ID: 19946935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.